Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide due to high recurrence rates after curative treatment and being frequently diagnosed at an advanced stage. Immune-checkpoint inhibition (ICPI) has yielded impressive clinical successes in a variety of solid...

Full description

Bibliographic Details
Main Authors: Lisanne Noordam, Monique T.A. de Beijer, Shanta Mancham, Isabel Vogler, Patrick P.C. Boor, Valeska de Ruiter, Robbie Luijten, Jan N.M. IJzermans, Ugur Sahin, Marco J. Bruno, Dave Sprengers, Sonja I. Buschow, Jaap Kwekkeboom
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:OncoImmunology
Subjects:
Liver neoplasms
tumor-associated antigens
immunotherapy
vaccination
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2022.2131096

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2022.2131096

Similar Items